APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurotrophins

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurotrophins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174016710319 December 2025180 pages

Choose your research edition.

Industry ResearchNeurotrophins Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotrophins Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotrophins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotrophins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotrophins Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Neurotrophins market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurotrophins include FibroGen, GE Healthcare, Merck Serono, PeproTech, Scil Proteins GmbH, Scil Proteins GmbH, Lonza Groups and Johnson＆Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurotrophins market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurotrophins and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurotrophins sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurotrophins market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurotrophins Segment by Company

FibroGen

GE Healthcare

Merck Serono

PeproTech

Scil Proteins GmbH

Scil Proteins GmbH

Lonza Groups

Johnson＆Johnson

Neurotrophins Segment by Type

Dehydroepiandrosterone Sulfate

Brain-Derived Neurotrophic Factor

Nerve Growth Factor

Other

Neurotrophins Segment by Application

Alzheimer'S Disease

Amyotrophic Lateral Sclerosis

Parkinson'S Disease

Other

Neurotrophins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotrophins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotrophins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotrophins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurotrophins market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurotrophins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurotrophins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurotrophins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurotrophins Industry Trends Table 2. Neurotrophins Industry Drivers Table 3. Neurotrophins Industry Opportunities and Challenges Table 4. Neurotrophins Industry Restraints Table 5. Global Neurotrophins Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurotrophins Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurotrophins Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Neurotrophins Sales Market Share by Manufacturers Table 9. Global Neurotrophins Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Neurotrophins Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurotrophins Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurotrophins Manufacturers, Product Type & Application Table 13. Global Neurotrophins Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurotrophins by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Dehydroepiandrosterone Sulfate Table 17. Major Manufacturers of Brain-Derived Neurotrophic Factor Table 18. Major Manufacturers of Nerve Growth Factor Table 19. Major Manufacturers of Other Table 20. Global Neurotrophins Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Neurotrophins Sales by Type (2021-2026) & (K Units) Table 22. Global Neurotrophins Sales by Type (2027-2032) & (K Units) Table 23. Global Neurotrophins Sales Market Share by Type (2021-2026) Table 24. Global Neurotrophins Sales Market Share by Type (2027-2032) Table 25. Global Neurotrophins Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Neurotrophins Revenue by Type (2021-2026) & (K Units) Table 27. Global Neurotrophins Revenue by Type (2027-2032) & (K Units) Table 28. Global Neurotrophins Revenue Market Share by Type (2021-2026) Table 29. Global Neurotrophins Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Alzheimer'S Disease Table 31. Major Manufacturers of Amyotrophic Lateral Sclerosis Table 32. Major Manufacturers of Parkinson'S Disease Table 33. Major Manufacturers of Other Table 34. Global Neurotrophins Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Neurotrophins Sales by Application (2021-2026) & (K Units) Table 36. Global Neurotrophins Sales by Application (2027-2032) & (K Units) Table 37. Global Neurotrophins Sales Market Share by Application (2021-2026) Table 38. Global Neurotrophins Sales Market Share by Application (2027-2032) Table 39. Global Neurotrophins Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Neurotrophins Revenue by Application (2021-2026) & (K Units) Table 41. Global Neurotrophins Revenue by Application (2027-2032) & (K Units) Table 42. Global Neurotrophins Revenue Market Share by Application (2021-2026) Table 43. Global Neurotrophins Revenue Market Share by Application (2027-2032) Table 44. Global Neurotrophins Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Neurotrophins Sales by Region (2021-2026) & (K Units) Table 46. Global Neurotrophins Sales Market Share by Region (2021-2026) Table 47. Global Neurotrophins Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Neurotrophins Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Neurotrophins Sales by Country (2021-2026) & (K Units) Table 51. North America Neurotrophins Sales by Country (2027-2032) & (K Units) Table 52. Europe Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Neurotrophins Sales by Country (2021-2026) & (K Units) Table 54. Europe Neurotrophins Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Neurotrophins Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Neurotrophins Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Neurotrophins Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Neurotrophins Sales by Country (2027-2032) & (K Units) Table 61. Global Neurotrophins Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Neurotrophins Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Neurotrophins Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Neurotrophins Revenue Market Share by Region (2021-2026) Table 65. Global Neurotrophins Revenue Market Share by Region (2027-2032) Table 66. FibroGen Company Information Table 67. FibroGen Business Overview Table 68. FibroGen Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. FibroGen Neurotrophins Product Portfolio Table 70. FibroGen Recent Development Table 71. GE Healthcare Company Information Table 72. GE Healthcare Business Overview Table 73. GE Healthcare Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GE Healthcare Neurotrophins Product Portfolio Table 75. GE Healthcare Recent Development Table 76. Merck Serono Company Information Table 77. Merck Serono Business Overview Table 78. Merck Serono Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Serono Neurotrophins Product Portfolio Table 80. Merck Serono Recent Development Table 81. PeproTech Company Information Table 82. PeproTech Business Overview Table 83. PeproTech Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. PeproTech Neurotrophins Product Portfolio Table 85. PeproTech Recent Development Table 86. Scil Proteins GmbH Company Information Table 87. Scil Proteins GmbH Business Overview Table 88. Scil Proteins GmbH Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Scil Proteins GmbH Neurotrophins Product Portfolio Table 90. Scil Proteins GmbH Recent Development Table 91. Scil Proteins GmbH Company Information Table 92. Scil Proteins GmbH Business Overview Table 93. Scil Proteins GmbH Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Scil Proteins GmbH Neurotrophins Product Portfolio Table 95. Scil Proteins GmbH Recent Development Table 96. Lonza Groups Company Information Table 97. Lonza Groups Business Overview Table 98. Lonza Groups Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Lonza Groups Neurotrophins Product Portfolio Table 100. Lonza Groups Recent Development Table 101. Johnson＆Johnson Company Information Table 102. Johnson＆Johnson Business Overview Table 103. Johnson＆Johnson Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Johnson＆Johnson Neurotrophins Product Portfolio Table 105. Johnson＆Johnson Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Neurotrophins Distributors List Table 109. Neurotrophins Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Neurotrophins Product Image Figure 2. Global Neurotrophins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotrophins Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurotrophins Sales (2021-2032) & (K Units) Figure 5. Global Neurotrophins Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurotrophins Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Dehydroepiandrosterone Sulfate Image Figure 9. Brain-Derived Neurotrophic Factor Image Figure 10. Nerve Growth Factor Image Figure 11. Other Image Figure 12. Global Neurotrophins Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Neurotrophins Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Neurotrophins Sales Market Share by Type (2021-2032) Figure 15. Global Neurotrophins Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Neurotrophins Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Neurotrophins Revenue Market Share by Type (2021-2032) Figure 18. Alzheimer'S Disease Image Figure 19. Amyotrophic Lateral Sclerosis Image Figure 20. Parkinson'S Disease Image Figure 21. Other Image Figure 22. Global Neurotrophins Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Neurotrophins Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Neurotrophins Sales Market Share by Application (2021-2032) Figure 25. Global Neurotrophins Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Neurotrophins Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Neurotrophins Revenue Market Share by Application (2021-2032) Figure 28. North America Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Neurotrophins Sales Market Share by Country (2021-2032) Figure 30. U.S. Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Neurotrophins Sales Market Share by Country (2021-2032) Figure 35. Germany Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Neurotrophins Sales Market Share by Country (2021-2032) Figure 42. China Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Neurotrophins Sales Market Share by Country (2021-2032) Figure 50. Brazil Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Neurotrophins Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Neurotrophins Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Neurotrophins Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Neurotrophins Revenue (2021-2032) & (US$ Million) Figure 61. North America Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Neurotrophins Revenue (2021-2032) & (US$ Million) Figure 63. Europe Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Neurotrophins Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Neurotrophins Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Neurotrophins Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Neurotrophins Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dehydroepiandrosterone Sulfate
  • Brain-Derived Neurotrophic Factor
  • Nerve Growth Factor
  • Other
Applications
  • Alzheimer'S Disease
  • Amyotrophic Lateral Sclerosis
  • Parkinson'S Disease
  • Other
Companies covered
  • FibroGen
  • GE Healthcare
  • Merck Serono
  • PeproTech
  • Scil Proteins GmbH
  • Scil Proteins GmbH
  • Lonza Groups
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurotrophins Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurotrophins Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurotrophins Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurotrophins Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurotrophins Market Dynamics
  1. 2.1 Neurotrophins Industry Trends
  2. 2.2 Neurotrophins Industry Drivers
  3. 2.3 Neurotrophins Industry Opportunities and Challenges
  4. 2.4 Neurotrophins Industry Restraints
3 Neurotrophins Market by Manufacturers
  1. 3.1 Global Neurotrophins Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurotrophins Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurotrophins Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurotrophins Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurotrophins Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurotrophins Manufacturers, Product Type & Application
  7. 3.7 Global Neurotrophins Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurotrophins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurotrophins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurotrophins Tier 1, Tier 2, and Tier 3
4 Neurotrophins Market by Type
  1. 4.1 Neurotrophins Type Introduction
  2. 4.1.1 Dehydroepiandrosterone Sulfate
  3. 4.1.2 Brain-Derived Neurotrophic Factor
  4. 4.1.3 Nerve Growth Factor
  5. 4.1.4 Other
  6. 4.2 Global Neurotrophins Sales by Type
  7. 4.2.1 Global Neurotrophins Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurotrophins Sales by Type (2021-2032)
  9. 4.2.3 Global Neurotrophins Sales Market Share by Type (2021-2032)
  10. 4.3 Global Neurotrophins Revenue by Type
  11. 4.3.1 Global Neurotrophins Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurotrophins Revenue by Type (2021-2032)
  13. 4.3.3 Global Neurotrophins Revenue Market Share by Type (2021-2032)
5 Neurotrophins Market by Application
  1. 5.1 Neurotrophins Application Introduction
  2. 5.1.1 Alzheimer'S Disease
  3. 5.1.2 Amyotrophic Lateral Sclerosis
  4. 5.1.3 Parkinson'S Disease
  5. 5.1.4 Other
  6. 5.2 Global Neurotrophins Sales by Application
  7. 5.2.1 Global Neurotrophins Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neurotrophins Sales by Application (2021-2032)
  9. 5.2.3 Global Neurotrophins Sales Market Share by Application (2021-2032)
  10. 5.3 Global Neurotrophins Revenue by Application
  11. 5.3.1 Global Neurotrophins Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Neurotrophins Revenue by Application (2021-2032)
  13. 5.3.3 Global Neurotrophins Revenue Market Share by Application (2021-2032)
6 Global Neurotrophins Sales by Region
  1. 6.1 Global Neurotrophins Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurotrophins Sales by Region (2021-2032)
  3. 6.2.1 Global Neurotrophins Sales by Region (2021-2026)
  4. 6.2.2 Global Neurotrophins Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurotrophins Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurotrophins Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurotrophins Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurotrophins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurotrophins Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurotrophins Revenue by Region
  1. 7.1 Global Neurotrophins Revenue by Region
  2. 7.1.1 Global Neurotrophins Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurotrophins Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurotrophins Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurotrophins Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurotrophins Revenue (2021-2032)
  8. 7.2.2 North America Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurotrophins Revenue (2021-2032)
  11. 7.3.2 Europe Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurotrophins Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurotrophins Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurotrophins Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 FibroGen
  2. 8.1.1 FibroGen Company Information
  3. 8.1.2 FibroGen Business Overview
  4. 8.1.3 FibroGen Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 FibroGen Neurotrophins Product Portfolio
  6. 8.1.5 FibroGen Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Neurotrophins Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 Merck Serono
  14. 8.3.1 Merck Serono Company Information
  15. 8.3.2 Merck Serono Business Overview
  16. 8.3.3 Merck Serono Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Serono Neurotrophins Product Portfolio
  18. 8.3.5 Merck Serono Recent Developments
  19. 8.4 PeproTech
  20. 8.4.1 PeproTech Company Information
  21. 8.4.2 PeproTech Business Overview
  22. 8.4.3 PeproTech Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PeproTech Neurotrophins Product Portfolio
  24. 8.4.5 PeproTech Recent Developments
  25. 8.5 Scil Proteins GmbH
  26. 8.5.1 Scil Proteins GmbH Company Information
  27. 8.5.2 Scil Proteins GmbH Business Overview
  28. 8.5.3 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  30. 8.5.5 Scil Proteins GmbH Recent Developments
  31. 8.6 Scil Proteins GmbH
  32. 8.6.1 Scil Proteins GmbH Company Information
  33. 8.6.2 Scil Proteins GmbH Business Overview
  34. 8.6.3 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  36. 8.6.5 Scil Proteins GmbH Recent Developments
  37. 8.7 Lonza Groups
  38. 8.7.1 Lonza Groups Company Information
  39. 8.7.2 Lonza Groups Business Overview
  40. 8.7.3 Lonza Groups Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lonza Groups Neurotrophins Product Portfolio
  42. 8.7.5 Lonza Groups Recent Developments
  43. 8.8 Johnson＆Johnson
  44. 8.8.1 Johnson＆Johnson Company Information
  45. 8.8.2 Johnson＆Johnson Business Overview
  46. 8.8.3 Johnson＆Johnson Neurotrophins Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Johnson＆Johnson Neurotrophins Product Portfolio
  48. 8.8.5 Johnson＆Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurotrophins Value Chain Analysis
  2. 9.1.1 Neurotrophins Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurotrophins Production Mode & Process
  6. 9.2 Neurotrophins Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurotrophins Distributors
  9. 9.2.3 Neurotrophins Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst